Who Paid My Doc
Phase 1/2a Moda+Dara RRMM
Research payments
$1,321,352
Through program year 2024, $1,321,352 in research payments was reported against Phase 1/2a Moda+Dara RRMM, across 215 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..
- Paid by
- Takeda Pharmaceuticals U.S.A., Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $556,920 | 88 |
| 2023 | Research | $764,432 | 127 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Richard Zuniga Lowell, MA Named on 35 payments
- Mark Schroeder Saint Louis, MO Named on 30 payments
- Sara Holstein Omaha, NE Named on 28 payments
- Suman Kambhampati Kansas City, MO Named on 24 payments
- Michael Schuster New York, NY Named on 21 payments
- William Derosa Morristown, NJ Named on 21 payments
- Sumit Madan Gilbert, AZ Named on 9 payments
- David Oveisi Los Angeles, CA Named on 9 payments
- Edward Faber Cincinnati, OH Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.